Actually, effectiveness against symptomatic infection was the primary endpoint of the trials. There weren't sufficient cases of severe illness in the vaccinated

Actually, effectiveness against symptomatic infection was the primary endpoint of the trials. There weren't sufficient cases of severe illness in the vaccinated or placebo groups to draw any conclusions from the trials about protection from hospitalization/death.